Literature DB >> 30779062

Suppression of connexin 43 expression by miR-106a promotes melanoma cell proliferation.

J-L Wang1, H Li, J-B Zhang, C-H Zhang, X-Q Hou.   

Abstract

OBJECTIVE: Connexin 43 (Cx43), a vital gap junction protein is reported to be involved in melanoma progression. The aim of the study is to investigate the regulatory role of Cx43 in melanoma.
MATERIALS AND METHODS: Western blot assay was used to detect the protein expression of Cx43 in melanoma cells and the human epidermal melanocytes (HEMn). MTT cell proliferation and cell colony formation assays were used to assess cell proliferation. Bioinformatics prediction, luciferase reporter assay, Western blot and qRT-PCR assays were applied to demonstrate that Cx43 was a direct target of miR-106a in melanoma cells.
RESULTS: Connexin 43 (Cx43) was lower expressed in melanoma cells compared with human epidermal melanocytes (HEMn). Cx43 overexpression significantly inhibited melanoma cell proliferation and colony formation ability in vitro. However, knockdown of Cx43 had opposite effects on cell proliferation and colony formation. Bioinformatics prediction and luciferase reporter assays demonstrated that miR-106a targeted the 3' untranslated region (3'UTR) of Cx43 and regulated its mRNA and protein expression levels in melanoma cells. MiR-106a was upregulated in melanoma cells, and its overexpression attenuated the effects caused by upregulating Cx43 expression.
CONCLUSIONS: Thus, our results indicated that Cx43 was downregulated in melanoma cells and may be a potential target of melanoma treatment.

Entities:  

Year:  2019        PMID: 30779062     DOI: 10.26355/eurrev_201902_16983

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

Review 1.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

2.  MiR-106a facilitates the sensorineural hearing loss induced by oxidative stress by targeting connexin-43.

Authors:  Lei Ding; Jiaxi Wang
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

3.  Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo.

Authors:  Hoda Y Abdallah; Noura R Abdelhamid; Eman A Mohammed; Nehal Y AbdElWahab; Noha Z Tawfik; Amal H A Gomaa; Eman A Toraih; Alia Ellawindy
Journal:  Sci Rep       Date:  2022-08-08       Impact factor: 4.996

4.  Effects of Alpha-Connexin Carboxyl-Terminal Peptide (aCT1) and Bowman-Birk Protease Inhibitor (BBI) on Canine Oral Mucosal Melanoma (OMM) Cells.

Authors:  Ayami Sato; Ivone Izabel Mackowiak da Fonseca; Márcia Kazumi Nagamine; Gabriela Fernandes de Toledo; Rennan Olio; Francisco Javier Hernandez-Blazquez; Tomohiro Yano; Elizabeth Shinmay Yeh; Maria Lucia Zaidan Dagli
Journal:  Front Vet Sci       Date:  2021-06-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.